Envestnet Asset Management Inc. Trims Stake in STERIS plc (NYSE:STE)

Envestnet Asset Management Inc. reduced its stake in STERIS plc (NYSE:STE - Free Report) by 14.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 466,268 shares of the medical equipment provider's stock after selling 75,705 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.47% of STERIS worth $95,846,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of STE. Avalon Trust Co purchased a new stake in shares of STERIS in the fourth quarter valued at about $30,000. Human Investing LLC bought a new stake in STERIS in the 4th quarter worth about $31,000. Anfield Capital Management LLC increased its stake in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC grew its holdings in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 137 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Performance

Shares of STE stock traded up $3.56 during trading on Monday, reaching $224.65. 54,073 shares of the company's stock traded hands, compared to its average volume of 553,306. The firm's 50-day moving average is $222.61 and its 200 day moving average is $219.50. The company has a market capitalization of $22.07 billion, a P/E ratio of 47.70 and a beta of 0.87. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. STERIS's dividend payout ratio (DPR) is currently 48.41%.

Analysts Set New Price Targets

A number of analysts recently issued reports on STE shares. Stephens restated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. JMP Securities restated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research note on Thursday. Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, STERIS presently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.